BSEAchyut Healthcare Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 24 Mar, 2026 · 18:58 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Akshit Raycha

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-7.4%Reaction day
₹5.70
prior close
₹5.64
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+2.4%-9.8% vs market
Pharmaceuticals peers, median of 158sector+1.7%-9.1% vs sector

On the reaction day the stock moved 9.8 pts less than Nifty Microcap 250 and 9.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.9
10m
+0.2
15m
+1.1
30m
+0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-7.4+2.4-9.8+1.7-9.1
Next day
-2.3-0.5-1.8-1.3-1.0
2d
-8.4-3.4-5.0-3.4-5.1
3d
-1.4+1.1-2.5+0.1-1.5
4d
-0.9+1.8-2.6+0.8-1.7
5d
-3.7+2.8-6.5+2.6-6.3
1w
-0.2+7.5-7.7+6.5-6.7
15d
-2.3+15.7-18.0+10.7-12.9
1m
-1.4+18.0-19.4+12.4-13.8
2m
+2.3+20.9-18.6+16.2-13.9
3m
+39.6+27.6+12.0+19.0+20.7
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 158Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

BSE has received a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, pertaining to a party named Akshit Raycha in Achyut Healthcare Ltd. The actual filing details could not be accessed because the source BSE page returned an error and was not available for review. As a result, the nature of the disclosure — whether it relates to an acquisition, sale, or change in voting rights — cannot be confirmed from the provided content.

Likely market impact

No actionable insight can be drawn for shareholders at this time, as the underlying disclosure (number of shares, transaction type, and whether the threshold trigger was crossed) is not visible in the retrieved document. Investors should check the full filing on BSE/NSE directly once accessible.